Rigel Suzuki

3.9k total citations
18 papers, 260 citations indexed

About

Rigel Suzuki is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rigel Suzuki has authored 18 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rigel Suzuki's work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers) and Viral Infections and Immunology Research (3 papers). Rigel Suzuki is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (4 papers) and Viral Infections and Immunology Research (3 papers). Rigel Suzuki collaborates with scholars based in Japan, France and South Korea. Rigel Suzuki's co-authors include Hiroyuki Kawahara, Takasuke Fukuhara, Shiho Torii, Yoshiharu Matsuura, Yuzy Fauzyah, Itsuki Anzai, Yuhei Morioka, Chikako Ono, Yusuke Maeda and Wataru Kamitani and has published in prestigious journals such as Nature Communications, The Journal of Cell Biology and Journal of Virology.

In The Last Decade

Rigel Suzuki

17 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rigel Suzuki Japan 8 123 122 38 37 27 18 260
Margherita Leonardi Italy 8 133 1.1× 60 0.5× 44 1.2× 24 0.6× 38 1.4× 12 224
Dominique Van Looveren Belgium 7 196 1.6× 127 1.0× 43 1.1× 12 0.3× 39 1.4× 11 305
Jimmy Rodriguez Murillo Sweden 10 87 0.7× 126 1.0× 37 1.0× 12 0.3× 31 1.1× 25 288
Alberto Zani Italy 12 193 1.6× 71 0.6× 75 2.0× 16 0.4× 47 1.7× 26 326
Marta Ciechonska Canada 7 88 0.7× 133 1.1× 31 0.8× 24 0.6× 54 2.0× 9 251
Adrian Coscia United States 6 173 1.4× 125 1.0× 38 1.0× 9 0.2× 44 1.6× 8 325
Enya Qing United States 9 282 2.3× 151 1.2× 45 1.2× 35 0.9× 58 2.1× 12 412
Jillian N. Whelan United States 7 146 1.2× 83 0.7× 51 1.3× 9 0.2× 89 3.3× 8 256
Tal Fisher Israel 5 135 1.1× 127 1.0× 36 0.9× 8 0.2× 71 2.6× 5 282
Joaquín López-Orozco Canada 11 159 1.3× 223 1.8× 66 1.7× 20 0.5× 91 3.4× 15 425

Countries citing papers authored by Rigel Suzuki

Since Specialization
Citations

This map shows the geographic impact of Rigel Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rigel Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rigel Suzuki more than expected).

Fields of papers citing papers by Rigel Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rigel Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rigel Suzuki. The network helps show where Rigel Suzuki may publish in the future.

Co-authorship network of co-authors of Rigel Suzuki

This figure shows the co-authorship network connecting the top 25 collaborators of Rigel Suzuki. A scholar is included among the top collaborators of Rigel Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rigel Suzuki. Rigel Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Iwasa, Yasushi, Shiro Miyata, Takuya Tomita, et al.. (2025). TanGIBLE: A selective probe for evaluating hydrophobicity-exposed defective proteins in live cells. The Journal of Cell Biology. 224(3). 1 indexed citations
2.
Suzuki, Rigel, Hayato Ito, Takahiro Tomiyama, et al.. (2024). The development of a rapid, high-throughput neutralization assay using a SARS-CoV-2 reporter. Journal of Virological Methods. 326. 114894–114894. 3 indexed citations
3.
Tamura, Tomokazu, Hirotaka Yamamoto, Yuhei Morioka, et al.. (2024). A rapid and versatile reverse genetics approach for generating recombinant positive-strand RNA viruses that use IRES-mediated translation. Journal of Virology. 98(3). e0163823–e0163823. 1 indexed citations
4.
Ito, Hayato, Tomokazu Tamura, Lei Wang, et al.. (2024). Involvement of SARS‐CoV‐2 accessory proteins in immunopathogenesis. Microbiology and Immunology. 68(7). 237–247. 1 indexed citations
5.
Takahashi, Toshiki, et al.. (2023). Protein quality control machinery supports primary ciliogenesis by eliminating GDP-bound Rab8-family GTPases. iScience. 26(5). 106652–106652. 3 indexed citations
6.
Torii, Shiho, Kwang Su Kim, Jun Koseki, et al.. (2023). Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir. PLoS Pathogens. 19(3). e1011231–e1011231. 13 indexed citations
7.
Tomiyama, Takahiro, Rigel Suzuki, Noboru Harada, et al.. (2023). A third dose of the BNT162b2 mRNA vaccine sufficiently improves the neutralizing activity against SARS-CoV-2 variants in liver transplant recipients. Frontiers in Cellular and Infection Microbiology. 13. 1197349–1197349. 4 indexed citations
8.
Ohashi, Hirofumi, Daisuke Akazawa, Shiho Torii, et al.. (2023). Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication. Viruses. 15(2). 452–452. 7 indexed citations
9.
Ode, Hirotaka, Tomokazu Tamura, Rigel Suzuki, et al.. (2023). saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern. Nature Communications. 14(1). 2810–2810. 17 indexed citations
10.
Tamura, Tomokazu, Shiho Torii, Kentaro Kajiwara, et al.. (2022). Secretory glycoprotein NS1 plays a crucial role in the particle formation of flaviviruses. PLoS Pathogens. 18(6). e1010593–e1010593. 7 indexed citations
11.
Tsuji, Genichiro, Koichi Watashi, Shiho Torii, et al.. (2022). Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication. Journal of Pharmacological Sciences. 149(3). 81–84. 4 indexed citations
12.
Suzuki, Rigel, Yuki Ono, Koji Noshita, et al.. (2022). Smoking enhances the expression of angiotensin‐converting enzyme 2 involved in the efficiency of severe acute respiratory syndrome coronavirus 2 infection. Microbiology and Immunology. 67(1). 22–31. 4 indexed citations
13.
Torii, Shiho, Chikako Ono, Rigel Suzuki, et al.. (2021). Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction. Cell Reports. 35(3). 109014–109014. 97 indexed citations
14.
Fauzyah, Yuzy, Chikako Ono, Shiho Torii, et al.. (2020). Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation. Antiviral Research. 186. 104999–104999. 15 indexed citations
15.
Suzuki, Rigel & Hiroyuki Kawahara. (2016). UBQLN 4 recognizes mislocalized transmembrane domain proteins and targets these to proteasomal degradation. EMBO Reports. 17(6). 842–857. 52 indexed citations
16.
Tanaka, Hirofumi, Toshiki Takahashi, Yiming Xie, et al.. (2015). A conserved island of BAG6/Scythe is related to ubiquitin domains and participates in short hydrophobicity recognition. FEBS Journal. 283(4). 662–677. 24 indexed citations
17.
Narimatsu, Kazuyuki, Paulo Henrique Luiz de Freitas, Sadia Sultana, et al.. (2010). Ultrastructural observation on cells meeting the histological criteria for preosteoblasts - a study in the mouse tibial metaphysis. Journal of Electron Microscopy. 59(5). 427–436. 7 indexed citations
18.
Shoji, Ikuo, Masayuki Shirakura, Tohru Ichimura, et al.. (2006). O.087 E6-associated protein mediates ubiquitylation and degradation of hepatitis C virus core protein. Journal of Clinical Virology. 36. S26–S26.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margherita Leonardi Breakdown of academic impact, for papers by Dominique Van Looveren Breakdown of academic impact, for papers by Jimmy Rodriguez Murillo Breakdown of academic impact, for papers by Alberto Zani Breakdown of academic impact, for papers by Marta Ciechonska Breakdown of academic impact, for papers by Adrian Coscia Breakdown of academic impact, for papers by Enya Qing Breakdown of academic impact, for papers by Jillian N. Whelan Breakdown of academic impact, for papers by Tal Fisher Breakdown of academic impact, for papers by Joaquín López-Orozco
Rankless by CCL
2026